Topical antibiotic therapy in chronic rhinosinusitis

an update

Daniel A. Carlton, D. David Beahm, Alexander G Chiu

Research output: Contribution to journalReview article

Abstract

Background: Topical antibiotic therapies have been investigated for their use in chronic rhinosinusitis (CRS). However, society guidelines and evidence-based medicine reviews have recommended against the use of topical antibiotic therapy based on randomized controlled trials (RCTs). The purpose of this article is to review recent clinical research published since the aforementioned guidelines were published. Methods: A structured literature review was performed on clinical studies published in the last 5 years investigating the use of topical antibiotic therapies. Results: One double-blinded, randomized controlled trial (DB-RCT) supported the use of tobramycin using a vibrating aerosolizer; 1 non-blinded non-randomized controlled prospective trial lent support to use of topical ofloxacin for its anti-biofilm properties; and 1 meta-analysis found mupirocin irrigations to be beneficial in the short term. One Cochrane Review was unable to make a recommendation as no trial met the inclusion criteria. An additional systematic review found limited evidence to support the use of topical antibiotics with the exception of mupirocin irrigations that may be considered in Staphylococcus aureus infections. Two retrospective studies found that topical antibiotics change bacterial cultures of the sinuses. Conclusion: There is additional evidence to support continuing investigation of topical antibiotic therapies. Further, larger RCTs are required to establish the efficacy of topical antibiotic therapies.

Original languageEnglish (US)
Pages (from-to)S27-S31
JournalInternational Forum of Allergy and Rhinology
Volume9
Issue numberS1
DOIs
StatePublished - May 1 2019
Externally publishedYes

Fingerprint

Anti-Bacterial Agents
Mupirocin
Randomized Controlled Trials
Therapeutics
Guidelines
Tobramycin
Ofloxacin
Evidence-Based Medicine
Biofilms
Staphylococcus aureus
Meta-Analysis
Retrospective Studies
Infection
Research

Keywords

  • Biofilm
  • Chronic Rhinosinustis
  • Topical Therapy for Chronic Rhinosinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Topical antibiotic therapy in chronic rhinosinusitis : an update. / Carlton, Daniel A.; Beahm, D. David; Chiu, Alexander G.

In: International Forum of Allergy and Rhinology, Vol. 9, No. S1, 01.05.2019, p. S27-S31.

Research output: Contribution to journalReview article

@article{d044e8d421394971a1082dc4669def56,
title = "Topical antibiotic therapy in chronic rhinosinusitis: an update",
abstract = "Background: Topical antibiotic therapies have been investigated for their use in chronic rhinosinusitis (CRS). However, society guidelines and evidence-based medicine reviews have recommended against the use of topical antibiotic therapy based on randomized controlled trials (RCTs). The purpose of this article is to review recent clinical research published since the aforementioned guidelines were published. Methods: A structured literature review was performed on clinical studies published in the last 5 years investigating the use of topical antibiotic therapies. Results: One double-blinded, randomized controlled trial (DB-RCT) supported the use of tobramycin using a vibrating aerosolizer; 1 non-blinded non-randomized controlled prospective trial lent support to use of topical ofloxacin for its anti-biofilm properties; and 1 meta-analysis found mupirocin irrigations to be beneficial in the short term. One Cochrane Review was unable to make a recommendation as no trial met the inclusion criteria. An additional systematic review found limited evidence to support the use of topical antibiotics with the exception of mupirocin irrigations that may be considered in Staphylococcus aureus infections. Two retrospective studies found that topical antibiotics change bacterial cultures of the sinuses. Conclusion: There is additional evidence to support continuing investigation of topical antibiotic therapies. Further, larger RCTs are required to establish the efficacy of topical antibiotic therapies.",
keywords = "Biofilm, Chronic Rhinosinustis, Topical Therapy for Chronic Rhinosinusitis",
author = "Carlton, {Daniel A.} and Beahm, {D. David} and Chiu, {Alexander G}",
year = "2019",
month = "5",
day = "1",
doi = "10.1002/alr.22338",
language = "English (US)",
volume = "9",
pages = "S27--S31",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "S1",

}

TY - JOUR

T1 - Topical antibiotic therapy in chronic rhinosinusitis

T2 - an update

AU - Carlton, Daniel A.

AU - Beahm, D. David

AU - Chiu, Alexander G

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background: Topical antibiotic therapies have been investigated for their use in chronic rhinosinusitis (CRS). However, society guidelines and evidence-based medicine reviews have recommended against the use of topical antibiotic therapy based on randomized controlled trials (RCTs). The purpose of this article is to review recent clinical research published since the aforementioned guidelines were published. Methods: A structured literature review was performed on clinical studies published in the last 5 years investigating the use of topical antibiotic therapies. Results: One double-blinded, randomized controlled trial (DB-RCT) supported the use of tobramycin using a vibrating aerosolizer; 1 non-blinded non-randomized controlled prospective trial lent support to use of topical ofloxacin for its anti-biofilm properties; and 1 meta-analysis found mupirocin irrigations to be beneficial in the short term. One Cochrane Review was unable to make a recommendation as no trial met the inclusion criteria. An additional systematic review found limited evidence to support the use of topical antibiotics with the exception of mupirocin irrigations that may be considered in Staphylococcus aureus infections. Two retrospective studies found that topical antibiotics change bacterial cultures of the sinuses. Conclusion: There is additional evidence to support continuing investigation of topical antibiotic therapies. Further, larger RCTs are required to establish the efficacy of topical antibiotic therapies.

AB - Background: Topical antibiotic therapies have been investigated for their use in chronic rhinosinusitis (CRS). However, society guidelines and evidence-based medicine reviews have recommended against the use of topical antibiotic therapy based on randomized controlled trials (RCTs). The purpose of this article is to review recent clinical research published since the aforementioned guidelines were published. Methods: A structured literature review was performed on clinical studies published in the last 5 years investigating the use of topical antibiotic therapies. Results: One double-blinded, randomized controlled trial (DB-RCT) supported the use of tobramycin using a vibrating aerosolizer; 1 non-blinded non-randomized controlled prospective trial lent support to use of topical ofloxacin for its anti-biofilm properties; and 1 meta-analysis found mupirocin irrigations to be beneficial in the short term. One Cochrane Review was unable to make a recommendation as no trial met the inclusion criteria. An additional systematic review found limited evidence to support the use of topical antibiotics with the exception of mupirocin irrigations that may be considered in Staphylococcus aureus infections. Two retrospective studies found that topical antibiotics change bacterial cultures of the sinuses. Conclusion: There is additional evidence to support continuing investigation of topical antibiotic therapies. Further, larger RCTs are required to establish the efficacy of topical antibiotic therapies.

KW - Biofilm

KW - Chronic Rhinosinustis

KW - Topical Therapy for Chronic Rhinosinusitis

UR - http://www.scopus.com/inward/record.url?scp=85065963827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065963827&partnerID=8YFLogxK

U2 - 10.1002/alr.22338

DO - 10.1002/alr.22338

M3 - Review article

VL - 9

SP - S27-S31

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - S1

ER -